TSTL - Ticker AI Digest

Tristel 📰 1
TradingFloor AI GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Tristel in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, crunch, and the deeper desks.
TSTL Data 2026-03-18 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (TSTL) 1
TSTL 06:01
Tristel
Conference attendance at ShareSoc Leeds
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
TSTL 15:05
Tristel
PCA Dealing
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 1
TSTL 06:01
Tristel
Half-year Financial Report
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Tristel PLCs Half-Year Financial Report (H1 FY26):**
Tristel PLC, a manufacturer of infection prevention products, reported strong unaudited interim results for the six months ended 31 December 2025, highlighting revenue growth and improved profitability. Key financial and operational highlights include
### **Financial Highlights**
**Revenue Growth** Revenue increased by 14% to £25.65 million (H1 FY25: £22.57 million), driven by strong performance across core markets.
**UK and Overseas Sales** UK sales rose 13% to £9.88 million, while overseas sales grew 14% to £15.77 million, with a sixfold increase in the USA.
**Gross Margin** Remained stable at 81% (H1 FY25: 82%).
**Profitability** Reported EBITDA rose to £6.83 million (H1 FY25: £5.02 million), with adjusted EBITDA up 17% to £7.34 million. Reported profit before tax increased 36% to £4.96 million, and adjusted profit before tax grew 11% to £5.47 million.
**EPS** Basic reported EPS increased 45% to 8.28p, and adjusted EPS rose to 9.36p.
**Cash Position** The company remains debt-free with cash and short-term investments of £13.29 million (H1 FY25: £11.74 million).
**Dividend** Interim dividend maintained at 5.68p per share.
### **Operational Highlights**
**Product Launches** Introduced Tristel OPH in the US for ophthalmic devices and VISICLEAN™ for improved cleaning efficiency.
**Regulatory Developments** Updated AIUM guidelines now include chlorine dioxide for ultrasound probe disinfection, enhancing adoption of Tristel ULT™ in the US.
**Manufacturing** Successfully transitioned to in-house wipe manufacture, expected to reduce unit costs in H2.
**Leadership** Appointed Anna Wasyl as CFO
CEO Matt Sassone announced his departure at the end of FY26.
### **Regional Performance**
**Americas** Revenue surged 236% year-on-year, with US sales increasing 542% due to strong ULT product sales and clinical validation.
**UK and EMEA** Double-digit growth in key markets like the Netherlands, France, Germany, and Italy.
**APAC** Mixed performance, with modest growth in Australasia and a 2% decline in the rest of the region.
### **Growth Initiatives**
Continued investment in commercial infrastructure, digital capabilities, and innovation pipeline.
Focus on clinical evidence generation and KOL engagement to support market adoption.
### **Outlook**
Tristel remains on track to meet market expectations for FY26, with international expansion, particularly in the US, driving growth. The company is well-positioned for long-term value creation despite the CEO transition.
**Conclusion**
Tristel PLC delivered robust H1 FY26 results, underpinned by strong revenue growth, improved profitability, and strategic advancements in key markets. The company’s debt-free position, progressive dividend policy, and focus on innovation reinforce its growth trajectory.
Here’s an HTML table comparing the financials and debt year on year for Tristel PLC based on the provided text:
MetricH1 FY25 (£'000)H1 FY26 (£'000)YOY Change (£'000)YOY Change (%)
Revenue22,57325,6483,07514%
Gross Profit18,47420,7762,30212%
Reported EBITDA5,0196,8251,80636%
Adjusted EBITDA6,2707,3401,07017%
Reported Profit Before Tax3,6574,9571,30036%
Adjusted Profit Before Tax4,9105,47056011%
Cash and Short-Term Investments11,74013,2901,55013%
Debt0000%
Interim Dividend (pence per share)5.685.6800%
### Key Observations: 1. **Revenue Growth**: Revenue increased by 14% year on year, driven by strong performance across core markets and significant growth in the USA. 2. **Profitability**: Both reported and adjusted profit before tax increased, with adjusted EBITDA rising by 17%. 3. **Cash Position**: Cash and short-term investments increased by 13%, maintaining a debt-free balance sheet. 4. **Dividend**: The interim dividend remained unchanged at 5.68 pence per share. This table provides a clear comparison of key financial metrics and debt status between H1 FY25 and H1 FY26 for Tristel PLC.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 1
TSTL 16:14
Tristel
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 4
TSTL 06:01
Tristel
Conference attendance at ShareSoc Leeds
TSTL 16:14
Tristel
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
TSTL 15:05
Tristel
PCA Dealing
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
TSTL 06:01
Tristel
Half-year Financial Report
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Tristel PLCs Half-Year Financial Report (H1 FY26):**
Tristel PLC, a manufacturer of infection prevention products, reported strong unaudited interim results for the six months ended 31 December 2025, highlighting revenue growth and improved profitability. Key financial and operational highlights include
### **Financial Highlights**
**Revenue Growth** Revenue increased by 14% to £25.65 million (H1 FY25: £22.57 million), driven by strong performance across core markets.
**UK and Overseas Sales** UK sales rose 13% to £9.88 million, while overseas sales grew 14% to £15.77 million, with a sixfold increase in the USA.
**Gross Margin** Remained stable at 81% (H1 FY25: 82%).
**Profitability** Reported EBITDA rose to £6.83 million (H1 FY25: £5.02 million), with adjusted EBITDA up 17% to £7.34 million. Reported profit before tax increased 36% to £4.96 million, and adjusted profit before tax grew 11% to £5.47 million.
**EPS** Basic reported EPS increased 45% to 8.28p, and adjusted EPS rose to 9.36p.
**Cash Position** The company remains debt-free with cash and short-term investments of £13.29 million (H1 FY25: £11.74 million).
**Dividend** Interim dividend maintained at 5.68p per share.
### **Operational Highlights**
**Product Launches** Introduced Tristel OPH in the US for ophthalmic devices and VISICLEAN™ for improved cleaning efficiency.
**Regulatory Developments** Updated AIUM guidelines now include chlorine dioxide for ultrasound probe disinfection, enhancing adoption of Tristel ULT™ in the US.
**Manufacturing** Successfully transitioned to in-house wipe manufacture, expected to reduce unit costs in H2.
**Leadership** Appointed Anna Wasyl as CFO
CEO Matt Sassone announced his departure at the end of FY26.
### **Regional Performance**
**Americas** Revenue surged 236% year-on-year, with US sales increasing 542% due to strong ULT product sales and clinical validation.
**UK and EMEA** Double-digit growth in key markets like the Netherlands, France, Germany, and Italy.
**APAC** Mixed performance, with modest growth in Australasia and a 2% decline in the rest of the region.
### **Growth Initiatives**
Continued investment in commercial infrastructure, digital capabilities, and innovation pipeline.
Focus on clinical evidence generation and KOL engagement to support market adoption.
### **Outlook**
Tristel remains on track to meet market expectations for FY26, with international expansion, particularly in the US, driving growth. The company is well-positioned for long-term value creation despite the CEO transition.
**Conclusion**
Tristel PLC delivered robust H1 FY26 results, underpinned by strong revenue growth, improved profitability, and strategic advancements in key markets. The company’s debt-free position, progressive dividend policy, and focus on innovation reinforce its growth trajectory.
Here’s an HTML table comparing the financials and debt year on year for Tristel PLC based on the provided text:
MetricH1 FY25 (£'000)H1 FY26 (£'000)YOY Change (£'000)YOY Change (%)
Revenue22,57325,6483,07514%
Gross Profit18,47420,7762,30212%
Reported EBITDA5,0196,8251,80636%
Adjusted EBITDA6,2707,3401,07017%
Reported Profit Before Tax3,6574,9571,30036%
Adjusted Profit Before Tax4,9105,47056011%
Cash and Short-Term Investments11,74013,2901,55013%
Debt0000%
Interim Dividend (pence per share)5.685.6800%
### Key Observations: 1. **Revenue Growth**: Revenue increased by 14% year on year, driven by strong performance across core markets and significant growth in the USA. 2. **Profitability**: Both reported and adjusted profit before tax increased, with adjusted EBITDA rising by 17%. 3. **Cash Position**: Cash and short-term investments increased by 13%, maintaining a debt-free balance sheet. 4. **Dividend**: The interim dividend remained unchanged at 5.68 pence per share. This table provides a clear comparison of key financial metrics and debt status between H1 FY25 and H1 FY26 for Tristel PLC.

AI Crunch

Single-Ticker AI Crunch
TSTL signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Tristel. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full TSTL AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for TSTL on 2026-03-18.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
185.7M
Enterprise Value
152.8M
Public Float
96.1
Broker Target
471.429
Shares Out
47.9M
Long Interest
80
Short Interest
20
Exchange
LSE
Currency Code
GBX
ISIN
GB00B07RVT99
Market
LSE - AIM
Sector
Health Care Providers
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for TSTL.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-03-18 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Tristel has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
06:01 Today's Alert Conference attendance at ShareSoc Leeds
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.14
Ex Divi
2026-03-19
Earnings Date
2026-02-23
Net Debt
-2.8M
Cash
8.6M
EPS
0.16
Net Income
6.6M
Revenue
46.5M
Enterprise Value
152.8M
Trailing PE
24.2188
Forward PE
20
Price Sales TTM
3.7879
Price Book MRQ
5.5359
EV Revenue
3.5987
EV EBITDA
13.8301
Financial Forecastist

Improving financial engine

Revenue is accelerating +22.5% against the prior comparable period. Net margin is stable by 0.7 pts. Net debt is coming down +204.1%.

Revenue +22.5% Net Income +28.3% FCF -1.4% Current Ratio 4.13x Forward Rev 0
Improving
Quarter Revenue
25.6M
+22.5%
vs prior comparable quarter
Net Margin
+15.4%
+0.7 pts
profitability pulse
Free Cash Flow
5.1M
-1.4%
cash conversion
Net Debt / EBITDA
-0.2x
-204.1%
lower is cleaner
Revenue Engine

Latest quarter printed 25.6M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 4.0M and the margin profile is stable. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 7.1M while net debt is -1.2M. The leverage stack is cleaning up.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q1 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2025
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
51.2M
Revenue Path
0.17
EPS / Earnings
Growth cue +0.0%
FY 2027
Consensus
56.2M
Revenue Path
0.20
EPS / Earnings
Growth cue +0.2%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 25.6M 4.0M 5.1M -1.2M
Q2 2025 23.9M 3.9M 4.9M -2.8M
Q4 2024 22.6M 2.7M 4.7M -5.8M
Q2 2024 21.0M 3.4M 4.8M -275.0K
Q4 2023 20.9M 3.1M 5.2M 1.2M
Q2 2023 18.5M 3.0M 2.8M -1.9M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 46.5M 6.6M 11.5M 9.5M
FY 2024 41.9M 6.5M 10.0M 10.1M
FY 2023 36.0M 4.5M 7.9M 6.1M
FY 2022 31.1M 987.0K 4.5M 4.3M
FY 2021 31.0M 3.7M 6.7M 4.7M

Structure DNA

Market Structure DNA

Income Anchor profile with trend mixed

Price is 57.9% through the 52-week range, -0.7% vs 50DMA and +1.2% vs 200DMA. 45.6% of the register is locked by institutions and insiders, leaving 54.4% free float. Capital rhythm reads semi-annual with forward yield near 3.7% and payout around 1.8%.

Trend mixed Institutional gravity Reliable income rhythm As Of 2026-04-19
Income Anchor
Structure Score
63.8 / 100
Income Anchor
Trend Stack
-0.7% / +1.2%
vs 50DMA / 200DMA
52W Position
57.9%
auction position inside the yearly range
Ownership Lock
45.6%
43.2% institutions | 2.4% insiders
Pressure Pocket
54.4% free float
Vendor short-float fields were not supplied
Capital Rhythm
Semi-Annual
Yield 3.7% | payout 1.8%
Trend Runway

Implied spot is 387.50 with the stock -0.7% vs 50DMA and +1.2% vs 200DMA. The tape is sitting 57.9% through the 52-week range, which frames the regime as trend mixed.

Ownership Register

Institutions hold about 43.2% and insiders about 2.4%, locking roughly 45.6% of the register and leaving 54.4% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads semi-annual with 2 event(s) in the last full year, a five-year average of 2.2, and stability score 80.0/100. Forward yield sits near 3.7% while payout is around 1.8%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Semi-Annual
Year Dividend Count Context
2026 1 Current partial year
2025 2 Full year
2024 2 Full year
2023 2 Full year
2022 3 Full year
2021 2 Full year
2020 2 Full year
2019 2 Full year

Structure Facts

Live Snapshot
Implied Spot
387.50
derived from market cap / shares
52W High
438.48
upper auction edge
52W Low
317.47
lower auction edge
Beta
0.29
volatility character
Shares Out
47.9M
fully diluted count
Shares Float
46.1M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
2026-03-19
-31 day(s) to ex-date
Dividend Pay
-
payment date not supplied
Last Split
-
split date not supplied

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.0327
Institutions As Of
2026-04-20
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
3
Purchase TR1
1
Sale TR1
7
Broker Coverage Rows
3
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for TSTL, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-03-18 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Tristel has fresh news flow live now, so the tape is framing the chart workspace below.
06:01 Today's Catalyst Conference attendance at ShareSoc Leeds
AI Charts Studio
TSTL Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-03-18 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 6.61%
RSI Gauge
Price Change
AI Forecast